Maxim: Our Vertex Pharma Thesis Is Unchanged By: Benzinga via Benzinga March 20, 2015 at 11:29 AM EDT In a report published Friday, Maxim Group analyst Jason Kolbert said that his thesis on Vertex Pharmaceuticals Incorporated (NASDAQ: ... Read More >> Related Stocks: Vertex Pharmaceuticals